Articles about Krishna Ella

Sleeves up! Coronavirus vaccination drive could begin on January 13

05 Jan 2021

India
Sleeves up! Coronavirus vaccination drive could begin on January 13

The first dose of the coronavirus vaccine in India will most likely be administered on January 13, a statement from a top official of the Union Health Ministry indicated on Tuesday.

SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

05 Jan 2021

India
SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally

The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.

COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns

04 Jan 2021

India
COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns

Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."

All you need to know about vaccines approved in India

03 Jan 2021

India
All you need to know about vaccines approved in India

Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.

Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here

23 Sep 2020

Technology
Bharat Biotech signs deal for nasal COVID-19 vaccine: Details here

In a major move, Bharat Biotech has signed an agreement to license a nasal COVID-19 vaccine developed by the Washington University School of Medicine in St. Louis, United States.

NewsBytes Briefing: TikTok plans to sue Trump administration, and more

10 Aug 2020

Technology
NewsBytes Briefing: TikTok plans to sue Trump administration, and more

Over the weekend, TikTok was reported to be planning legal action against Trump administration.

COVAXIN will cost less than water bottle: Bharat Biotech MD

04 Aug 2020

India
COVAXIN will cost less than water bottle: Bharat Biotech MD

Ever since companies started developing vaccines for COVID-19, one big question has been on everyone's mind: how much the final, approved shot would cost to the public?

AIIMS vaccine trials: 80% volunteers found unfit for study

04 Aug 2020

Technology
AIIMS vaccine trials: 80% volunteers found unfit for study

Nearly two weeks ago, AIIMS Delhi had started the Phase 1 human trial of COVAXIN — the first candidate vaccine developed indigenously in India to fight the spread of COVID-19.

AIIMS Delhi starts human trials of India's first COVID-19 vaccine

24 Jul 2020

India
AIIMS Delhi starts human trials of India's first COVID-19 vaccine

The All India Institute of Medical Science (AIIMS) in Delhi has started human trials of COVAXIN, the country's first indigenously developed vaccine to prevent the novel coronavirus disease COVID-19.

India's COVID-19 vaccines: What are the latest updates?

17 Jul 2020

India
India's COVID-19 vaccines: What are the latest updates?

In the race to develop a vaccine for the novel coronavirus disease (COVID-19), two pharma companies are leading the way from India - Bharat Biotech and Zydus Cadila.

Following globally-accepted norms, says ICMR over August 15 vaccine target

04 Jul 2020

India
Following globally-accepted norms, says ICMR over August 15 vaccine target

The Indian Council of Medical Research (ICMR) on Saturday said that it is acting in accordance with globally-accepted norms by setting a mid-August target for developing a COVID-19 vaccine.